跳至主要内容
临床试验/NCT04141358
NCT04141358
已完成
不适用

Using Ultrasound 2D Strain Speckle Tracking, 2D Shear Wave Elastography and Transonic Flowmeter as Diagnostic and Potential Predictor Tool for Arteriovenous Fistula Outcomes With End Stage Renal Failure.

Imperial College London1 个研究点 分布在 1 个国家目标入组 76 人2021年11月1日

概览

阶段
不适用
干预措施
Advanced ultrasound measurements
疾病 / 适应症
End Stage Renal Diseases
发起方
Imperial College London
入组人数
76
试验地点
1
主要终点
Patency of arteriovenous fistula according to ultrasound parameters
状态
已完成
最后更新
上个月

概览

简要总结

Haemodialysis is a renal replacement therapy that can be introduced to patients with end-stage renal disease (ESRD) to help them maintain a good healthy life. The patient's blood is pumped through a dialysis machine to remove excess fluid, salt and waste, then it is pumped back into the patient's circulation system. In order to carry out haemodialysis, vascular access (VA) is required to connect the patient to the dialysis machine. Patients have only three options of vascular access: arteriovenous fistula (AVF), an anastomosis between a native vein and an artery; arteriovenous graft (AVG), a connection between a synthetic tube and native blood vessels; and (3) central line, a cuffed catheter placed in a large neck vein. Arteriovenous fistulas are the preferred method for VA because of their longevity and causing the least number of complications. Although there are a number of factors that may increase the probability of AVF failure rate such as age and gender of the patient, poor native vessel structure, medications and the level of surgical experience, 30-40% of new AVFs fail to mature for unknown reasons. For an AVF to become functionally mature postoperative, remodelling and dilation of the native artery and vein are essential to accommodate significantly increased blood flow. However, pre-existing diseases in patients with ESRD such as arterial stiffness and endothelial dysfunction may impair AVF and preclude dialysis. It has been asserted that the lack of AVF success is attributable to insufficient arterial dilation because of poor arterial wall elasticity.

The study aims to investigate the role of arterial stiffness and endothelial dysfunction in predicting AVF outcome using novel non-invasive ultrasound applications: 2D shear wave elastography and 2D strain speckle tracking will be employed to assess arterial stiffness, while an intraoperative flow-mediated dilation (FMD) technique will be used to evaluate endothelial dysfunction.

详细描述

This is an observational prospective pilot study of patients with end-stage renal disease (ESRD), who will be referred for AVF procedure. Duration: 21 Months The research team will collect data from the patients after they have signed the informed consent form. Data collection will take place before, during and after arteriovenous fistula (AVF) surgery. At 0 week, the patient will be interviewed to obtain clinical information. Also, blood pressure and body mass index will be checked and recorded. Next, pre-operative AVF assessment ultrasound measurements will be performed to assess flow, pulsatility and vessel diameter. Advanced ultrasound applications(2D strain speckle tracking and 2D Shear wave elastography) will be applied to assess arterial stiffness as additional measurement tools. These are quantitative measures of vessel stiffness. It takes less than five minutes to obtain these measurements from the imaged vessel. During AVF surgery, the endothelial function will be assessed intraoperatively by testing the ability of the endothelium to dilate, flow mediation dilation (FMD). Leftover vessel specimens will be collected for histopathological analysis purpose. At 6 week, post-AVF ultrasound assessment will be conducted to assess the maturation of AVF by measuring ultrasound parameters of blood flow, pulsatility and vessel diameter. Arterial stiffness parameters will be measured as well. Blood pressure and BMI will be assessed and recorded. Study data will be entered into a study database which will consist of a password encrypted stored on a password-protected computer in the vascular lab at Hammersmith Hospital. Only the study researchers will know the study database password. Data analysis will be performed after the enrolment of 20, 40 and 75 patients.

注册库
clinicaltrials.gov
开始日期
2021年11月1日
结束日期
2024年4月1日
最后更新
上个月
研究类型
Observational
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • \>18 years age
  • \<90 years age
  • End stage renal disease
  • Glomerular filtration rate \< 30 ml/min/1.73m2

排除标准

  • \<18 years age
  • \> 90 years age
  • \< 2cm vein diameter
  • Not end-stage renal disease
  • Pregnant patients will not be recruited in this study. Patients pregnancy status will be assessed on initial enrolment to exclude them from the study.
  • Those unable to provide consent.
  • Anyone who is taking part in any other research.
  • Potential participants who might not adequately understand verbal explanations or written information given in English, or who have special communication needs will not be included

研究组 & 干预措施

Study group

Patients with end-stage renal disease who will undergo arteriovenous fistula (AVF) surgery will be recruited and follow-up them up to 6 weeks or until the AVF become suitable for hemodialysis.

干预措施: Advanced ultrasound measurements

结局指标

主要结局

Patency of arteriovenous fistula according to ultrasound parameters

时间窗: 6 Weeks

Rate of blood volume flow \>400 mL/min.

Arteriovenous fistula diameter

时间窗: 6 Weeks

Fistula considered to be patent if there is a minimum venous diameter of ≥ 5 mm.

次要结局

  • Number of arteriovenous fistula successful use for haemodialysis.(10 weeks)

研究点 (1)

Loading locations...

相似试验